Corcept Therapeutics Incorporated
US ˙ NasdaqCM ˙ US2183521028

SecurityCORT / Corcept Therapeutics Incorporated
InstitutionParallel Advisors, LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Parallel Advisors, LLC ownership in CORT / Corcept Therapeutics Incorporated

On June 2, 2026 - Parallel Advisors, LLC filed a 13F-HR/A form disclosing ownership of 0 shares of Corcept Therapeutics Incorporated (US:CORT) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 3,879,141 shares of Corcept Therapeutics Incorporated. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Parallel Advisors, LLC has a history of taking positions in derivatives of the underlying security (CORT) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CORT / Corcept Therapeutics Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-06-02 2026-03-31 13F/A-1 CORCEPT THERAPEUTICS INC COM Stock 218352102 0 -3,879,141 -100.00 0 -100.00
2026-02-11 2025-12-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 3,879,141 7,689 0.20 134,994 -58.04 2.4694
2025-11-13 2025-09-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 3,871,452 329 0.01 321,756 13.24 5.8916
2025-07-08 2025-06-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 3,871,123 -101,293 -2.55 284,140 29.36 5.6783
2025-04-08 2025-03-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 3,972,416 142,784 3.73 219,646 13.82 4.9530
2025-02-10 2024-12-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 3,829,632 15,908 0.42 192,975 9.33 4.3404
2024-11-13 2024-09-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 3,813,724 -2,036 -0.05 176,499 42.37 4.1493
2024-08-08 2024-06-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 3,815,760 83 0.00 123,974 28.98 3.1761
2024-05-06 2024-03-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 3,815,677 47,432 1.26 96,117 -21.47 2.6047
2024-02-12 2023-12-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 3,768,245 44,762 1.20 122,393 20.65 3.6310
2024-05-20 2023-09-30 13F/A-1 CORCEPT THERAPEUTICS INC COM Stock 218352102 3,723,483 -3,082 -0.08 101,446 22.35 3.3792
2023-11-14 2023-09-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 3,723,483 -3,082 101,446 3.3792
2024-05-20 2023-06-30 13F/A-1 CORCEPT THERAPEUTICS INC COM Stock 218352102 3,726,565 1,992 0.05 82,916 2.78 2.6697
2023-08-04 2023-06-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 3,726,565 1,992 82,916 2.6697
2024-05-20 2023-03-31 13F/A-1 CORCEPT THERAPEUTICS INC COM Stock 218352102 3,724,573 -91 -0.00 80,674 6.65 2.7201
2023-04-25 2023-03-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 3,724,573 -91 80,674 2.7201
2023-02-06 2022-12-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 3,724,664 -44,791 -1.19 75,648 -21.73 3.2804
2022-11-10 2022-09-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 3,769,455 1,051,127 38.67 96,649 49.51 4.4487
2022-08-01 2022-06-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 2,718,328 774,009 39.81 64,642 37.50 2.9667
2022-04-28 2022-03-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 1,944,319 140,937 7.82 47,014 31.67 1.8655
2022-01-20 2021-12-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 1,803,382 76,474 4.43 35,707 5.06 1.3257
2021-11-02 2021-09-30 13F/A-1 CORCEPT THERAPEUTICS INC COM Stock 218352102 1,726,908 52,551 3.14 33,986 -7.74 1.3705
2021-08-06 2021-06-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 1,674,357 110,383 7.06 36,836 -1.00 1.5601
2021-04-23 2021-03-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 1,563,974 15,358 0.99 37,207 -8.16 1.7555
2021-02-02 2020-12-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 1,548,616 253,712 19.59 40,512 79.75 2.1991
2020-10-27 2020-09-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 1,294,904 -109,541 -7.80 22,538 -4.59 1.3946
2020-07-16 2020-06-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 1,404,445 -1,450 -0.10 23,622 41.31 1.5417
2020-04-27 2020-03-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 1,405,895 0 0.00 16,716 -1.73 1.3535
2020-01-30 2019-12-31 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 1,405,895 128,044 10.02 17,011 -5.82 1.2760
2019-11-01 2019-09-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 1,277,851 1,275,251 49,048.12 18,062 62,182.76 1.5466
2019-08-05 2019-06-30 13F CORCEPT THERAPEUTICS INC COM Stock 218352102 2,600 2,600 29 0.0028
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-01-19 2021-12-31 13F CORCEPT THERAPEUTICS INC COM Stock Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-10-22 2021-09-30 13F CORCEPT THERAPEUTICS INC COM Stock Call 1,674,357 36,836 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.